Follow
Tejaswini Reddi
Tejaswini Reddi
Harvard University
Verified email at post.harvard.edu
Title
Cited by
Cited by
Year
Tripartite Motif 22 (TRIM22) protein restricts herpes simplex virus 1 by epigenetic silencing of viral immediate-early genes
T Reddi, P Merkl, SY Lim, N Letvin, D Knipe
Plos Pathogens, 2021
172021
Moving Genomics to Routine Care: An Initial Pilot in Acute Cardiovascular Disease
Z Aryan, A Szanto, A Pantazi, T Reddi, C Rheinstein, W Powers, E Wilson, ...
Circulation: Genomic and Precision Medicine, 2020
132020
TRIM22 is a novel restriction factor of herpesviruses
TS Reddi
Harvard University, 2015
2015
Abstract# 450: Loss of Tpl2 enhances tumorigenesis and affects tumor phenotype during promotion
J Simmons, K DeCicco-Skinner, J Pandey, Z Shan, T Reddi, J Wiest
Cancer Research 69 (9_Supplement), 450-450, 2009
2009
The Intricacies of Skin Cancer: A Tpl2 knockout enhances tumorigenesis and affects tumor phenotype during promotion
T Reddi, K DeCicco, J Simmons, Z Shan, J Weist
The system can't perform the operation now. Try again later.
Articles 1–5